Harvest Fund Management’s Transmedics TMDX Stock Holding History

Harvest Fund Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-255	Closed	-$31K	–	602
2025 Q4	$31K	Hold	255	–	–	﹤0.01%	449
2025 Q3	$29K	Buy	+255	New	+$29.9K	﹤0.01%	475

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harvest Fund Management's TMDX Position: Q1 2026 in Review

Harvest Fund Management sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 255 shares — an estimated $31K sold.

Harvest Fund Management first reported a position in TMDX in Q3 2025 and held it in 2 quarters. The position peaked at $31K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Harvest Fund Management reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Harvest Fund Management sold 255 Transmedics shares in Q1 2026, an estimated $31K.
Harvest Fund Management first reported a position in Transmedics in Q3 2025 and held it in 2 quarters.
Harvest Fund Management's Transmedics position peaked at $31K in Q4 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.